Physician profile

John F Harb

Urology · Livonia, MI

NPI 1811967334

$21,115.95

in general payments reported to CMS, 2019-2025

45 companies · $1,837 in 2025

The $1,837 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Consulting Fee$5,000.00
Food and Beverage$3,936.95
Travel and Lodging$1,477.57
Education$54.99

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Medtronic, INC. $8,419.81 2021-2025 Interstim
Neotract INC. $2,728.32 2019-2020
Teleflex LLC $2,264.53 2021-2025 Urolift, Barrigel
Coloplast Corp $1,732.08 2019-2025 Porges Coloplast
Astellas Pharma US INC $904.03 2019-2025 Xtandi, Myrbetriq
Medtronic USA, INC. $771.65 2019-2020
Pfizer INC. $691.91 2019-2025
Janssen Biotech, INC. $465.39 2019-2025 Erleada, Akeega
Laborie Medical Technologies Corp. $399.99 2022-2025 Optilume Bph Drug Coated Balloon Catheter, Endosheath Technology
Dendreon Pharmaceuticals LLC $361.30 2019
Endo Pharmaceuticals INC. $255.01 2019-2024 Xiaflex
Axonics, INC. $162.19 2020-2022
Blue Earth Diagnostics $161.17 2019-2021
Myovant Sciences INC. $142.72 2021-2022
Boston Scientific Corporation $142.49 2020-2025 Ams 700, Ams 800 Artificial Urinary Sphincter, Greenlight Xps
Show all 45 companies
CompanyGeneral paymentsYearsTop products
Tolmar, INC. $130.64 2023-2025 Eligard, Jatenzo
Procept Biorobotics Corporation $130.46 2021-2022
Tolmar Pharmaceuticals, INC. $121.01 2022
Olympus America INC. $99.92 2022-2025 Itind System, Soltive
Merck Sharp & Dohme LLC $67.21 2020-2024 Lynparza
Urovant Sciences INC $66.84 2022
Novartis Pharmaceuticals Corporation $65.00 2024-2025
Urogen Pharma, INC. $64.72 2021-2025
Allergan, INC. $64.48 2019-2021
Endo USA, INC. $63.64 2024-2025 Xiaflex
Immunitybio, INC. $60.58 2024
Seagen INC. $54.99 2025
Sumitomo Pharma America, INC. $44.73 2023-2025 Gemtesa
Accord Healthcare, INC. $42.52 2023
Ferring Pharmaceuticals INC. $41.17 2024 Adstiladrin
Abbvie INC. $37.40 2022
Metuchen Pharmaceuticals $34.90 2019
Caldera Medical, INC $33.35 2022
180 Medical, INC. $31.17 2023
Bayer Healthcare Pharmaceuticals INC. $30.78 2025
Cook Medical LLC $30.13 2021
Ambu INC. $28.91 2024
Biotissue Holdings INC. $28.04 2025
Avyxa Pharma, LLC $27.88 2025
Janssen Scientific Affairs, LLC $27.20 2022
Progenics Pharmaceuticals, INC. $23.55 2024
Abc Home Medical Supply, INC. $19.21 2025
Sagent Pharmaceuticals $17.89 2019
Myriad Genetic Laboratories, INC. $14.89 2021
Valencia Technologies Corporation $10.15 2025 Ecoin Device Kit

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

John F Harb

$21,115.95

in general payments reported 2019-2025

Years
2019-2025
Top company
Medtronic, INC.
Context
The $1,837 reported for 2025 was more than what 78% of Urology providers received nationally (typical 2025 total: $631).

https://glasscript.com/doctor/264174/john-f-harb

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.